FDA Import Refusal AEK-2072307-7/30004/1 — Bayer S.A.
The FDA refused shipment AEK-2072307-7/30004/1 from Bayer S.A. (Brazil) on Oct 21, 2026. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Oct 21, 2026
- Country
- Brazil
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75